CDX2 and neoplasm: These findings demonstrate that CDX2-reinstatement acts as a trigger for broader transcriptomic reprogramming that selectively suppresses CSC programs unique to CDX2-low tumors, while sparing normal stem cells in healthy colon and CDX2-high tumor cells.